Robin Shane Readnour Sells 35,402 Shares of Anthem (NASDAQ:ANTX) Stock

Anthem, Inc. (NASDAQ:ANTX) Director Robin Shane Readnour sold 35,402 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $6.01, for a total transaction of $212,766.02. Following the completion of the sale, the director owned 565,592 shares of the company’s stock, valued at $3,399,207.92. This trade represents a 5.89% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Anthem Stock Performance

ANTX stock opened at $5.79 on Friday. Anthem, Inc. has a fifty-two week low of $1.00 and a fifty-two week high of $7.19. The company has a market capitalization of $218.51 million, a price-to-earnings ratio of -5.41 and a beta of -0.99. The business’s 50 day moving average price is $5.14 and its two-hundred day moving average price is $3.98.

Anthem (NASDAQ:ANTX) last released its earnings results on Tuesday, August 11th. The company reported ($0.18) EPS for the quarter.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anthem in a research report on Monday, July 6th. Wall Street Zen raised shares of Anthem from a “sell” rating to a “hold” rating in a research report on Sunday, June 14th. Guggenheim started coverage on shares of Anthem in a research note on Monday, July 20th. They set a “buy” rating and a $9.00 price objective on the stock. Finally, Leerink Partners upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price objective on the stock in a report on Thursday, May 14th. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $9.00.

Institutional Investors Weigh In On Anthem

Institutional investors have recently modified their holdings of the stock. Vivo Capital LLC bought a new position in Anthem in the 1st quarter worth about $10,785,000. Commodore Capital LP bought a new stake in Anthem during the 1st quarter valued at about $7,981,000. Spruce Street Capital LP purchased a new position in Anthem in the first quarter worth about $5,576,000. Ally Bridge Group NY LLC purchased a new position in Anthem in the first quarter worth about $1,800,000. Finally, Seven Fleet Capital Management LP bought a new position in shares of Anthem in the first quarter worth approximately $683,000. 90.47% of the stock is owned by hedge funds and other institutional investors.

Anthem Company Profile

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.